Evidence mapPaperPMID 42130714Full record

ReviewACS pharmacology & translational science2026

Overview of the Current Osteoarthritis Treatment in Veterinary Medicine and Future Directions.

Nara L M Quintão, Eduardo B Moffa, Maria Kroier, Rodrigo C Goldoni, Louise Bundgaard, Asger L Jensen, Elizabeth S Fernandes

Abstract readReview
In one paragraph

Review in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nara L M QuintãoPrograma de Pós-graduação em Ciências Farmacêuticas, Universidade do Vale do Itajai, Itajai, SC 88302-901, Brazil.
Eduardo B MoffaCollege of Dentistry, University of Saskatchewan, Saskatoon S7N 5E5, Canada.
Maria KroierDepartment of Animal and Veterinary Sciences, Aarhus University, Tjele 8830, Denmark.
Rodrigo C GoldoniPrograma de Pós-graduação em Ciências Farmacêuticas, Universidade do Vale do Itajai, Itajai, SC 88302-901, Brazil.ORCID https://orcid.org/0000-0003-1628-9139
Louise BundgaardDepartment of Animal and Veterinary Sciences, Aarhus University, Tjele 8830, Denmark.ORCID https://orcid.org/0000-0002-0396-883X
Asger L JensenDepartment of Animal and Veterinary Sciences, Aarhus University, Tjele 8830, Denmark.ORCID https://orcid.org/0000-0003-2048-9221
Elizabeth S FernandesDepartment of Animal and Veterinary Sciences, Aarhus University, Tjele 8830, Denmark.ORCID https://orcid.org/0000-0002-0567-2514

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a chronic and progressive joint disease that can cause permanent loss of joint function. OA is highly prevalent in horses, dogs, and cats, affecting different joints and leading to reduced mobility and chronic pain. Different risk factors for animal OA have been identified, including trauma and breed. Inflammation is a hallmark of the disease, with various underlying mechanisms such as cyclooxygenase and metalloproteinase activation, nerve growth factor, cytokine, and prostaglandin

Indexed as

available therapiesmechanisms of diseasenovel treatmentsosteoarthritis

Identifiers

PMID42130714
PMCPMC13162164

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.